Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
2.
Immunol Lett ; 99(2): 169-79, 2005 Jul 15.
Artigo em Inglês | MEDLINE | ID: mdl-16009267

RESUMO

Fcgamma receptor (FcgammaR)-mediated phagocytosis by mononuclear phagocytes is an essential function in host defense. This process is initiated by crosslinking of membrane FcgammaRs, which induces phosphorylation and activation of Src and Syk tyrosine kinases. Activation of these enzymes is essential for initiating the biochemical cascade that results in the cytoskeletal and membrane changes involved in phagocytosis. Phagocytic capacity and other effector functions of mononuclear phagocytes change during differentiation/maturation of these cells. This is a complex process governed by different soluble and micro-environmental factors, giving rise to populations of cells with distinct phenotypic characteristics. Several agents, including calcitriol, have been shown to induce in vitro differentiation-related phenotypic changes in monocytic cell lines. In this paper, we characterized the changes in the initial biochemical signals associated with the increase in FcgammaR-mediated phagocytosis induced by calcitriol in monocytic U-937 cells. The 10-fold increase in phagocytic capacity is not accompanied by an increase in FcgammaR expression. However, the phosphorylation levels of Lyn and Syk after FcgammaRI or FcgammaRII crosslinking are increased after calcitriol treatment. Our results suggest that signaling induced by FcgammaR in mononuclear phagocytes is not only dependent on the quantity of FcgammaRs aggregated by a stimulus, but it is highly dependent on the cell's differentiation state.


Assuntos
Calcitriol/farmacologia , Diferenciação Celular/efeitos dos fármacos , Precursores Enzimáticos/metabolismo , Monócitos/efeitos dos fármacos , Proteínas Tirosina Quinases/metabolismo , Quinases da Família src/metabolismo , Precursores Enzimáticos/biossíntese , Citometria de Fluxo , Humanos , Peptídeos e Proteínas de Sinalização Intracelular , Receptores de Lipopolissacarídeos/efeitos dos fármacos , Receptores de Lipopolissacarídeos/metabolismo , Monócitos/imunologia , Monócitos/metabolismo , Fagocitose/efeitos dos fármacos , Fosforilação , Proteínas Tirosina Quinases/biossíntese , RNA/isolamento & purificação , Receptores de Complemento/efeitos dos fármacos , Receptores de Complemento/metabolismo , Receptores de IgG/efeitos dos fármacos , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Quinase Syk , Fatores de Tempo , Células U937 , Quinases da Família src/biossíntese
3.
Cancer Lett ; 198(2): 179-86, 2003 Aug 20.
Artigo em Inglês | MEDLINE | ID: mdl-12957356

RESUMO

This study determined the in vitro effects of 4-hydroxycoumarin (4-HC) employing the melanoma cell line B16-F10 and the non-malignant fibroblastic cell line B82. 4-HC disorganized the actin cytoskeleton in B16-F10 cells, but not in B82 fibroblasts. Cytoskeletal disorganization correlated with reductions in cell adhesion to four extracellular matrix proteins and inhibition of random motility. 4-HC did not modify cell viability or actin expression, but decreased tyrosine phosphorylation of several proteins in melanoma cells. Because adhesion of tumor cells to extracellular matrix is required during the metastatic process, 4-HC might be useful as an adjuvant therapy for melanoma.


Assuntos
4-Hidroxicumarinas/farmacologia , Actinas/efeitos dos fármacos , Adesão Celular/efeitos dos fármacos , Citoesqueleto/efeitos dos fármacos , Proteínas da Matriz Extracelular/metabolismo , Animais , Movimento Celular/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Citoesqueleto/ultraestrutura , Proteínas da Matriz Extracelular/efeitos dos fármacos , Fibroblastos/citologia , Fibroblastos/efeitos dos fármacos , Fibroblastos/fisiologia , Melanoma Experimental/fisiopatologia , Camundongos , Proteínas de Neoplasias/efeitos dos fármacos , Proteínas de Neoplasias/metabolismo , Fosfotirosina/metabolismo , Células Tumorais Cultivadas
4.
FEMS Immunol Med Microbiol ; 34(4): 255-66, 2002 Dec 13.
Artigo em Inglês | MEDLINE | ID: mdl-12443825

RESUMO

Complement receptor 3 (CR3) is an integrin that recognizes several different ligands. Binding to CR3 in phagocytic cells activates signaling pathways involved in cytoskeleton rearrangement, regulation of cell motility, alteration of gene expression and phagocytosis of complement-opsonized as well as of some non-opsonized particles and pathogenic bacteria. However, CR3-mediated phagocytosis of some Gram-negative bacteria does not induce bacterial clearance. Pseudomonas aeruginosa, Salmonella and Escherichia coli are eliminated after phagocytic cell-bacteria interaction mediated by CR3. However, Bordetella takes advantage of the CR3 function and uses it to enter into macrophages leading to bacterial survival. The final fate of the pathogen is determined by combinations of host and bacterial factors, in which molecular interactions between CR3 and bacterial ligands are involved.


Assuntos
Bactérias Gram-Negativas/imunologia , Fagócitos/metabolismo , Fagocitose , Receptores de Complemento/metabolismo , Bactérias Gram-Negativas/metabolismo , Humanos
5.
Microb Pathog ; 35(3): 125-31, 2003 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-12927520

RESUMO

Tuberculosis is the leading infectious disease in the world. Mycobacterium tuberculosis, the causal agent of this disease, invades macrophages and can replicate inside them. Because invasion of macrophages is a critical step for establishing a mycobacterial infection, there is much interest in understanding the mechanisms for M. tuberculosis entry into macrophages. Complement receptor 3 (CR3) is a heterodimeric surface receptor with multiple binding sites, which can mediate complement-opsonized as well as nonopsonic entrance of M. tuberculosis into macrophages. Here, we describe and discuss the role of CR3 in macrophage[bond]M. tuberculosis interactions. The actual information suggests that CR3 mediates a substantial amount of M. tuberculosis binding to macrophages, but CR3 is not related to the mechanisms that allow mycobacteria to survive and replicate intracellularly. Understanding the mechanisms of macrophage[bond]M. tuberculosis interaction will help developing more effective methods to prevent and treat tuberculosis in the future.


Assuntos
Antígeno de Macrófago 1/metabolismo , Macrófagos/imunologia , Macrófagos/microbiologia , Mycobacterium tuberculosis/imunologia , Mycobacterium tuberculosis/patogenicidade , Animais , Humanos , Camundongos , Fagocitose/fisiologia , Tuberculose/imunologia , Tuberculose/microbiologia , Tuberculose/fisiopatologia
6.
J Cell Biochem ; 89(5): 1056-76, 2003 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-12874838

RESUMO

In monocytes and macrophages, activation of the tyrosine kinase Syk is an essential step in the biochemical cascade linking aggregation of receptors for immunoglobulin G (FcgammaR) to initiation of effector functions. An increase in Syk activation during differentiation of myeloid cells by different agents has been reported. We studied the activation state of Syk in response to FcgammaRII crosslinking in monocytic cells before and after in vitro differentiation with 1alpha, 25-dihydroxy-vitamin D3. We show here that while in undifferentiated THP-1 cells clustering of FcgammaRII induces significant phosphorylation and activation of Syk, in THP-1 cells differentiated in vitro by 1alpha, 25-dihydroxy-vitamin D3, FcgammaRII crosslinking induced a decrease in Syk activity. In vitro differentiation did not induce changes in the expression of FcgammaRII isoforms. The observed effect on Syk activation though FcgammaRII could be mediated by differentiation-induced changes in the expression and basal activation level of Syk, as well as changes in the association of Syk with the tyrosine phosphatase SHP-1. These results suggest that the biochemical signaling pathways induced by FcgammaRII could be dependent on the differentiation state of the cell.


Assuntos
Calcitriol/farmacologia , Precursores Enzimáticos/metabolismo , Monócitos/metabolismo , Proteínas Tirosina Quinases/metabolismo , Receptores de IgG/metabolismo , Animais , Diferenciação Celular/efeitos dos fármacos , Linhagem Celular , Reagentes de Ligações Cruzadas/farmacologia , Primers do DNA/genética , Ativação Enzimática/efeitos dos fármacos , Precursores Enzimáticos/química , Eritrócitos/metabolismo , Humanos , Peptídeos e Proteínas de Sinalização Intracelular , Fagocitose/efeitos dos fármacos , Fagocitose/fisiologia , Fosforilação , Isoformas de Proteínas/metabolismo , Proteína Tirosina Fosfatase não Receptora Tipo 6 , Proteínas Tirosina Fosfatases/metabolismo , Proteínas Tirosina Quinases/química , Receptores de IgG/genética , Ovinos , Quinase Syk , Vanadatos/farmacologia , Domínios de Homologia de src
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA